JCVI publishes advice on COVID-19 vaccines for autumn booster programme
Following on from yesterday’s announcement that the Joint Committee on Vaccination and Immunisation will offer Moderna’s new bivalent vaccine as part of the autumn Covid booster rollout, please find below a series of social media posts which you are welcome to share with your networks and audiences, to spread awareness and understanding.
Clip of Deputy Chief Medical Officer Thomas Waite, explaining how bivalent vaccines can help protect you:
https://twitter.com/DHSCgovuk/status/1559236195263168517
https://fb.watch/eX6wglNy8Q/
https://www.linkedin.com/feed/update/urn:li:activity:6965249804897558529
Posts on Moderna authorisation:
https://twitter.com/DHSCgovuk/status/1559151753492369409
https://fb.watch/eX6E8jL28v/
https://www.linkedin.com/feed/update/urn:li:activity:6964919003274170368
Health and Social Care Secretary Steve Barclay said:
“I have accepted the independent advice of the Joint Committee on Vaccination and Immunisation (JCVI) on which vaccines should be offered in this autumn’s booster programme. This includes a Moderna bivalent vaccine which will target two different variants – the Omicron and original strain of Covid.
“Vaccines remain our best defence against Covid, and this safe and effective vaccine will broaden immunity and potentially improve protections against some variants as we learn to live with this virus.
“Our vaccine rollout to date has been world leading – it has already saved countless lives and reduced the pressure on the NHS.
“We will begin to contact those eligible from early September, and I would urge people to come forward as soon as they are invited so together we can keep each safe and protect our NHS.”
Background
The NHS will outline further deployment details in due course
All adults and children aged 5 and over on the learning disabilities register and with multiple and severe learning disabilities will be eligible for an autumn booster.
The UKHSA Green Book, which contains Covid vaccination information for public health professionals, will be updated in due course based on the final advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).